Lakefront Biotherapeutics (LKFT) Work In Process (2021 - 2023)

Lakefront Biotherapeutics (LKFT) has 3 years of Work In Process data on file, last reported at $13.6 million in Q4 2023.

• Work In Process for Q4 2023 came in at $13.6 million, up 129.42% year-over-year; the trailing twelve-month figure through Dec 2023 was $13.6 million (up 129.42% YoY), and the FY2023 annual result was $13.6 million, up 129.42% from the prior year.
• Work In Process climbed to $13.6 million in Q4 2023 per LKFT's latest filing, from $5.9 million in the prior quarter.
• Over five years, Work In Process peaked at $13.6 million in Q4 2023 and troughed at $1.6 million in Q4 2021.
• A 3-year average of $7.0 million and a median of $5.9 million in 2022 frame the typical range for Work In Process.
• The sharpest annual moves came in 2022 and 2023: Work In Process jumped 275.34% in 2022, then soared 129.42% in 2023.
• A 3-year view of Work In Process shows it stood at $1.6 million in 2021, then jumped by 275.34% to $5.9 million in 2022, then soared by 129.42% to $13.6 million in 2023.
• Business Quant data shows LKFT's Work In Process at $13.6 million in Q4 2023, $5.9 million in Q4 2022, and $1.6 million in Q4 2021.